ArticleJournal of inflammation research2025
Swainsonine Protects Human Thyrocytes from Fas-Induced Apoptosis: In vitro Study on Nthy-Ori 3-1 Cell Line.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The role of Fas is crucial for preserving immunotolerance. The mechanisms and roles of Fas/FasL signaling in the immune system are well understood, but the knowledge of how this process is regulated remains limited. Fas-mediated apoptosis is a way of thyrocyte elimination and thyroid destruction in Hashimoto's thyroiditis (HT). Proinflammatory cytokines, produced abundantly by immune cells in the thyroid in HT, stimulate the expression of Fas in thyrocytes, making them susceptible to apoptosis induced by FasL on the immune cell surface. Purpose: The present study aimed to evaluate the impact of changes in Fas Methods: To induce thyrocyte apoptosis, an in vitro model was established. Cells were stimulated with IFNγ to express Fas and treated with the Results: We found that swainsonine reduces Nthy-ori 3-1 cell apoptosis, caspase 3 and 7 activity, and restores mitochondrial potential. DAPI staining showed a decreased rupture and fragmentation of Nthy-ori 3-1 cell nuclei in the presence of swainsonine. The protective effect of kifunensine was only shown in the TMRE assay and for the late apoptotic cells in annexin V Conclusion: Our study demonstrated for the first time the anti-apoptotic effect of swainsonine on follicular thyroid cell death through the Fas/FasL signaling pathway. This finding may have later applications in controlling Fas/FasL-induced thyrocyte apoptosis and preventing thyroid destruction in HT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.